Information on coronavirus (SARS-CoV-2)
This page provides an overview of the most important information currently available on coronavirus. This information has been collated by Charité – Universitätsmedizin Berlin and is being updated on a regular basis.
You are here:
Charité press releases on coronavirus (SARS-CoV-2)
Nature article: SARS-CoV-2 disrupts timing of immune response
COVID-19: What is driving the escalating hyperinflammation
Study published in Nature suggests novel treatment option
Prior exposure to common cold coronaviruses enhances immune response to SARS-CoV-2
Understanding lung damage in patients with COVID-19
Model to serve as basis for new therapeutic strategies
A tapeworm drug against SARS-CoV-2?
Charité conducts clinical trial to test potential new treatment